Cell Therapy Technologies Market: Market Size and Market Share

According to a recently released Fact.MR analysis, the global market for Cell Treatment Technologies is expected to generate US$ 4.5 billion in revenue in 2022 and is predicted to expand at a CAGR of 14.4% from 2023 to 2033. It is anticipated that the market will be valued US$ 19.6 billion by the end of 2033. The top three cell therapy technology items are sera, media, and reagents together. The market for these products is anticipated to expand at a predicted 14.2% CAGR between 2023 and 2033.

Technologies for cell treatment have evolved in terms of consistency, safety, and efficacy. Growing prevalence of long-term illnesses such multiple myeloma, solid tumors, lymphomas, leukemia, and blood cancers is the main factor propelling the market for cell treatment technologies. The development of new cell types, gene editing methods, and biomaterials, are the advanced cell therapy technologies used more frequently in both research and clinical settings.

Get Free Sample Copy of This Report:

https://www.factmr.com/connectus/sample?flag=Srep_id=8754

CAR-T cell therapy is a type of immunotherapy that involves modifying a patient's T cells to recognize and attack cancer cells. This therapy has shown promising results in the treatment of certain types of blood cancer, and several CAR-T cell therapies have been approved by regulatory agencies in the United States and Europe.

According to research, around 437 thousand new cases of leukemia were diagnosed worldwide and 309 thousand leukemia-related cancer deaths were reported in 2018. CAR T cell therapy was frequently used by the medical practitioner for the treatment of particular type of leukemia. Thus, it is anticipated that the market for cell therapy technologies will grow in the upcoming years.

In 2020, the Chinese government invested over US$ 15.5 billion in the biopharmaceutical industry, which includes cell therapy technologies. Due to increase in funding by the government, investors, and venture capitalists influence the growth of cell therapy technologies.

Country-Wise Analysis:

United States Cell Therapy Technologies Market Study:

The market in the United States is anticipated to increase by US$ 3.3 billion in absolute terms from 2023 to 2033, reaching a value of US$ 4.4 billion. From 2018 to 2022, the market in the United States grew at a CAGR of 11.7%, and from 2023 to 2033, it is anticipated to grow at a CAGR of 14.2%.

Also, the American Food and Drug Administration (FDA) has taken action to promote the creation of cell therapy treatments. The FDA introduced its Regenerative Medicine Advanced Treatment (RMAT) designation programme in 2017, which offers regenerative medicine products—including cell therapy—advanced technology and review. In order to advance the development of cell therapy, the government has launched a number of programmes and offers

Competitive Analysis:

Key players in the market are:-

Thermo Fischer Scientific, Inc.,
Merck KGaA,
Danaher Corporation,
Lonza Group,
Sartorius,
Terumo BCT,
Becton Dickinson and Company,
Fresenius SE Co. KGaA,
Avantor Inc.,
Bio-Techne Corporation,
Corning Incorporated,
FUJIFILM Irvine Scientific,
MaxCyte Inc.,
RoosterBio Inc.

A few of the recent developments in the cell therapy technologies market are:

In June 2022, Bio-Techne Corporation, a global provider of innovative tools and bioactive reagents for the research and clinical diagnostic acquired Namocell, a leading provider of fast and easy to use single cell sorting and dispensing platforms that are gentle to cells, and preserve cell viability and integrity.
In February 2020, Immatics Biotechnologies GmbH collaborates with GSK, for the identification, research and development of next-generation T-Cell Receptor (TCR) Therapeutics with a focus on solid tumors.

Get Customization on this Report for Specific Research Solutions:

https://www.factmr.com/connectus/sample?flag=RCrep_id=8754

Segmentation of the Cell Therapy Technologies Market:

By Product:

Media, Sera, and Reagents
Cell Engineering Products
Cell Culture Vessels
Cell Therapy Equipment
Cell Processing Equipment
Single-use Equipment
Systems and Software

By Process:

Cell Processing
Cell Preservation, Distribution, and Handling
Process Monitoring and Quality Control

By Cell Type:

T-cells
Stem Cells
Other Cells

By End User:

Biopharmaceutical Biotechnology Companies
CROs and CMOs
Research Institutes and Cell Banks

By Region:

North America
Latin America
Europe
Asia Pacific
Middle East Africa

Browse Full Report @ https://www.factmr.com/report/cell-therapy-technologies-market

More Insights Available

Fact.MR, in its new offering, presents an unbiased analysis of the cell therapy technologies market, presenting historical market data (2018-2022) and forecast statistics for the period from 2023 to 2033.

The study reveals extensive growth in Cell Therapy Technologies Market by Product (Media, Sera, and Reagents, Cell Engineering Products, Cell Culture Vessels, Cell Therapy Equipment, Cell Processing Equipment, Single-use Equipment, Systems and Software), by Process (Cell Processing, Cell Preservation, Distribution, and Handling, Process Monitoring and Quality Control), by Cell Type (T-cells, Stem Cells, Other Cells), by End User (Biopharmaceutical Biotechnology Companies, CROs and CMOs, Research Institutes and Cell Banks), and by Region (North America, Latin America, Europe, Asia- Pacific , Middle East and Africa) from 2023 to 2033